Viewing Study NCT06925269


Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2026-01-01 @ 6:26 PM
Study NCT ID: NCT06925269
Status: RECRUITING
Last Update Posted: 2025-04-30
First Post: 2025-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: DMD Voice: Qualitative Interviews With Patients and Caregivers
Sponsor: Red Nucleus Enterprise Solutions, LLC
Organization:

Study Overview

Official Title: Duchenne Muscular Dystrophy Quality of Life: Qualitative Interviews With Patients and Caregivers
Status: RECRUITING
Status Verified Date: 2025-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to understand DMD functional losses or abilities and their association with independence and quality of life from the perspective of individuals with DMD and/or and their caregivers.

This is a qualitative interview study in which individuals with DMD and/or their caregivers will be asked to participate in a semi-structured, approximately 60- minute interview. Interviews will focus on functional abilities and independence. Caregivers and boys with DMD will be interviewed. This study includes no treatment nor intervention; however, some participants are being treated by a drug that is approved in the U.S. and the U.K. and under investigation in other geographies.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: